在选择临床试验适当结果的关键因素
Carlos Cabrera-Ubilla1, Vicente Nuñez-Galleguillos1, Javier Bracchiglione1
1Escuela de Medicina, Universidad de Valparaíso, Viña del Mar, Chile.
Medwave
|May 15, 2024
概括
在健康研究中选择正确的结果对于基于证据的决策至关重要. 这涉及使用患者报告的结果,临床相关措施,以及更好的医疗保健的核心结果集.
科学领域:
- 卫生研究 卫生研究 卫生研究
- 临床决策 - 临床决策
- 证据综合 证据综合
背景情况:
- 健康研究推动了医学知识和医疗保健政策.
- 选择适当的研究结果对于产生可靠的证据至关重要.
- 医疗保健中的有效决策依赖于可靠的研究结果.
研究的目的:
- 提出治疗干预研究中选择适当结果的关键因素.
- 强调以患者为中心的结果测量的重要性.
- 突出标准化成果报告在研究中的作用.
主要方法:
- 该研究提出了选择结果的三个基本标准.
- 专注于患者报告的健康状况和生活质量的结果 (PROs).
- 包含用于直接测量健康状况的临床相关结果.
- 利用核心结果集 (COS) 进行标准化测量和解释.
主要成果:
- 患者报告的结果捕捉了患者对其健康状况的观点.
- 临床相关的结果为决策提供了决定性的数据.
- 核心成果集简化证据生产和综合.
结论:
- 适当的结果选择提高了以患者为中心的护理.
- 有助于优化医疗保健和临床研究的资源配置.
- 标准化和相关的结果改善了证据生态系统,以获得更好的健康决策.
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Guidelines for Writing Outcome
2.8K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
2.8K
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
2.2K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
2.2K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K


